⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001722858

Satlin Andrew

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

8

Companies

1

Filings

4

CIK

0001722858

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-02-18	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	EVP and Chief Medical Officer	AAward	+26.8K sh	—	—	26,754
2020-02-18	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	EVP and Chief Medical Officer	AAward	+33.4K sh	—	—	33,417
2020-01-09	Intra-Cellular Therapies, Inc.S Sale	EVP and Chief Medical Officer	SSale	−11.6K sh	$26.16	−$303K	11,338
2020-01-08	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP and Chief Medical Officer	MExercise/Conversion	+22.9K sh	—	—	22,911
2020-01-08	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP and Chief Medical Officer	MExercise/Conversion	−22.9K sh	—	—	45,824
2019-01-08	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	EVP and Chief Medical Officer	AAward	+94.4K sh	—	—	94,443
2019-01-08	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	EVP and Chief Medical Officer	AAward	+68.7K sh	—	—	68,735
2017-11-13	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	EVP and Chief Medical Officer	AAward	+171K sh	—	—	170,500

Recent filings

4

Accepted (ET)
Feb 204
Satlin Andrew0001209191-20-011303
SEC(opens sec.gov)
Jan 104
Satlin Andrew0001209191-20-003150
SEC(opens sec.gov)
Jan 104
Satlin Andrew0001209191-19-003261
SEC(opens sec.gov)
Nov 154
Satlin Andrew0001209191-17-060943
SEC(opens sec.gov)

Companies

1

Intra-Cellular Therapies, Inc.EVP and Chief Medical Officer

Address

C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET

NEW YORK, NY, 10016